Assets

Assets


Unique selling points

  • access to large patients cohorts
  • translational approaches going from bench-to-bedside (and vice versa)
  • scientific excellence in many fields
  • clinical expertise, both in the field of neurology and neuropsychiatry
  • focus on the field of genes and the brain
  • open screening approaches in the field of explorative neurobiology
  • unique collections of biomaterials
  • strong infrastructures


Instead of offering individual services, we aim at providing industrial partners with integrated (i.e. end-to-end) propositions, including both a clinical and an explorative biology component. Innovation is secured through the use of the latest technology, the translational neuroscience perspective and an optimal one-stop-shop service model.